TrialMedicine2018

Treatment rationale and design of the RAMNITA study: A phase II study of the efficacy of docetaxel + ramucirumab for non-small cell lung cancer with brain metastasis.

Keiko Tanimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.